These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10655366)

  • 1. Problems related to determination of MICs of oximino-type expanded-spectrum cephems for Proteus vulgaris.
    Ohno A; Ishii Y; Ma L; Yamaguchi K
    J Clin Microbiol; 2000 Feb; 38(2):677-81. PubMed ID: 10655366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common system controls the induction of very different genes. The class-A beta-lactamase of Proteus vulgaris and the enterobacterial class-C beta-lactamase.
    Datz M; Joris B; Azab EA; Galleni M; Van Beeumen J; Frère JM; Martin HH
    Eur J Biochem; 1994 Nov; 226(1):149-57. PubMed ID: 7957242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enzymatic resistance to beta lactam antibiotics within the genus Proteus and evaluation of Proteus mirabilis phenotypes and genotypes for resistance to third- and fourth-generation cephalosporins].
    Rodríguez C; Radice M; Perazzi B; Castro S; Juárez J; Santini P; Vay C; Famiglietti A; Gutkind G
    Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):122-6. PubMed ID: 15757582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii.
    Yang YJ; Livermore DM
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1385-91. PubMed ID: 3058021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of extended-spectrum beta-lactamase PER-1 in Proteus vulgaris and Providencia stuartii isolates from Algiers, Algeria.
    Iabadene H; Dallenne C; Messai Y; Geneste D; Bakour R; Arlet G
    Antimicrob Agents Chemother; 2009 Sep; 53(9):4043-4. PubMed ID: 19546365
    [No Abstract]   [Full Text] [Related]  

  • 6. Recovery of active beta-lactamases from Proteus vulgaris and RTEM-1 hybrid by random mutagenesis by using a dnaQ strain of Escherichia coli.
    Hosseini-Mazinani SM; Nakajima E; Ihara Y; Kameyama KZ; Sugimoto K
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2152-9. PubMed ID: 8878598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of beta-lactamase in Proteus vulgaris.
    Okonogi K; Kuno M; Higashide E
    J Gen Microbiol; 1986 Jan; 132(1):143-50. PubMed ID: 3519851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomally encoded cephalosporin-hydrolyzing beta-lactamase of Proteus vulgaris RO104 belongs to Ambler's class A.
    Péduzzi J; Reynaud A; Baron P; Barthélémy M; Labia R
    Biochim Biophys Acta; 1994 Jul; 1207(1):31-9. PubMed ID: 8043607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical antibacterial activities of beta-lactams against Proteus vulgaris: mechanism of the paradoxical effect.
    Ikeda Y; Nishino T
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1073-7. PubMed ID: 3056246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical antibacterial activity of cefmenoxime against Proteus vulgaris.
    Ikeda Y; Nishino T; Tanino T
    Antimicrob Agents Chemother; 1987 Jun; 31(6):865-9. PubMed ID: 3304155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and beta-lactam resistance of Proteus vulgaris in hospital infections: the last decade.
    Gomez-Alferez A; Baquero F; Canton R; Loza E; Martinez-Beltran J
    J Chemother; 1991 Oct; 3(5):283-8. PubMed ID: 1809807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro antibacterial activities of cefteram and other beta-lactam agents against recent clinical isolates].
    Yamaguchi K; Ohno A; Takahashi S; Hayashi M; Yamanaka K; Hirakata Y; Mitsuyama J
    Jpn J Antibiot; 1998 Jan; 51(1):11-25. PubMed ID: 9557273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 Mar; 33(3):453-64. PubMed ID: 8040111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a modified double-disc synergy test for detection of extended spectrum beta-lactamases in AMPC beta-lactamase-producing proteus mirabilis.
    Khan MK; Thukral SS; Gaind R
    Indian J Med Microbiol; 2008; 26(1):58-61. PubMed ID: 18227600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef.
    Biedenbach DJ; Jones RN
    J Clin Microbiol; 1994 Feb; 32(2):559-62. PubMed ID: 8150976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic in vitro studies of antibacterial effects of the combination of new penicillins and cefalosporins against Proteus vulgaris.
    Dalhoff A; Gehl AE; Lode H
    Chemotherapy; 1982; 28(5):381-9. PubMed ID: 6754281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and expression of the gene(s) for chromosome-mediated beta-lactamase production of Proteus vulgaris in Escherichia coli.
    Maejima T; Ohya Y; Mitsuhashi S; Inoue M
    Plasmid; 1987 Sep; 18(2):120-6. PubMed ID: 2829250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1989; 12(6):495-510. PubMed ID: 2560422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.